自身免疫性胰腺炎诊治新进展  

Advances in diagnosis and treatment of autoimmune pancreatitis

作　　者：段春兰[1] 张爱民[1] 

机构地区：[1]包头医学院第一附属医院消化内科,包头014010

出　　处：《中国当代医药》2014年第13期189-190,193,共3页China Modern Medicine

摘　　要：自身免疫性胰腺炎是由免疫炎症介导,以腹部不适、梗阻性黄疸等为主要临床表现的特殊类型的胰腺炎。其以胰腺肿大、胰管不规则狭窄为特征,常伴有血清IgG4升高、高球蛋白血症及自身抗体阳性。根据病理学特征分为1型和2型,对糖皮质激素治疗敏感。Autoimmune panereatitis （AIP） is a special type of pancreatitis and it is mediated by immune inflammatory, abdominal discomfort, obstructive jaundice is the main clinical manifestations of AIP,and it is characterized by the swelling of the pancreas and the irregular stenosis of pancreatic duct,it often accompanied by elevated serum IgG4,hypergammaglobulinemia and positive autoantibodies.According to the pathological features,it is divided into type 1 and type 2,it is sensitive to glucocorticoid therapy.

关 键 词：自身免疫性胰腺炎 诊断标准 激素治疗 

分 类 号：R657.51[医药卫生—外科学]